ECHINOCANDIN AND ETHANOL LOCK THERAPY TREATMENT OF FUNGAL CATHETER INFECTIONS

被引:14
|
作者
Pieroni, Kevin P. [1 ]
Nespor, Colleen [2 ]
Poole, Robert L. [2 ,3 ]
Kerner, John A., Jr. [1 ,2 ]
Berquist, William E. [1 ]
机构
[1] Stanford Univ, Sch Med, Div Gastroenterol Hepatol & Nutr, Dept Pediat, Palo Alto, CA 94304 USA
[2] Childrens Home Pharm, Palo Alto, CA USA
[3] Lucile Packard Childrens Hosp Stanford, Dept Pharm, Palo Alto, CA 94304 USA
关键词
ethanol locks; catheter infection; fungal infections; BLOOD-STREAM INFECTIONS; PARENTERAL-NUTRITION PATIENTS; CANDIDA-ALBICANS BIOFILMS; INTESTINAL FAILURE; PEDIATRIC-PATIENTS; ANTIFUNGAL AGENTS; EFFICACY; REDUCE;
D O I
10.1097/INF.0b013e3182784867
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Ethanol lock therapy has been implemented to prevent infections of central venous catheters as well as to treat infections. Fungal catheter-associated blood stream infections are historically more difficult to treat and have required removal of central venous catheters. We report the largest case series to date, successfully treating 5 of 7 fungal catheter-associated blood stream infections with ethanol lock therapy and systemic echinocandin administration.
引用
收藏
页码:289 / 291
页数:3
相关论文
共 50 条
  • [21] Preemptive Ethanol Lock Therapy in Pediatric Hematology/Oncology Patients With Catheter-Associated Bloodstream Infection: Impact on Length of Stay, Cost, and Catheter Salvage
    McGrath, Eric
    Du, Wei
    Rajpurkar, Madhvi
    CLINICAL PEDIATRICS, 2018, 57 (03) : 285 - 293
  • [22] Ethanol Lock Therapy: A Pilot Infusion Study in Infants
    Chhim, Rebecca F.
    Crill, Catherine M.
    Collier, Hailey K.
    Arnold, Sandra R.
    Pourcyrous, Massroor
    Meibohm, Bernd
    Christensen, Michael
    ANNALS OF PHARMACOTHERAPY, 2015, 49 (04) : 431 - 436
  • [23] Ethanol-Lock Therapy for the Prevention of Central Venous Access Device Infections in Pediatric Patients With Intestinal Failure
    Cober, M. Petrea
    Kovacevich, Debra S.
    Teitelbaum, Daniel H.
    JOURNAL OF PARENTERAL AND ENTERAL NUTRITION, 2011, 35 (01) : 67 - 73
  • [24] Comparison of the effect of antibiotic-lock and ethanol-lock methods on infection rate in children with hemodialysis catheter
    Merikhi, Alireza
    Gheysari, Alaleh
    Madihi, Yahya
    Mehrkash, Mehryar
    Poorebrahim, Enayatollah
    Ghambarinia, Leila
    AMERICAN JOURNAL OF CLINICAL AND EXPERIMENTAL UROLOGY, 2019, 7 (06): : 384 - 390
  • [25] Ethanol Lock Therapy (E-Lock) in the Prevention of Catheter-Related Bloodstream Infections (CR-BSI) after Major Heart Surgery (MHS): A Randomized Clinical Trial
    Jesus Perez-Granda, Maria
    Maria Barrio, Jose
    Munoz, Patricia
    Hortal, Javier
    Rincon, Cristina
    Martin Rabadan, Pablo
    Sagrario Pernia, Maria
    Bouza, Emilio
    PLOS ONE, 2014, 9 (03):
  • [26] Hidden morbidity of ethanol lock therapy
    Teerin T. Meckmongkol
    Caitlyn Costanzo
    Sean Ciullo
    Rajeev Prasad
    L. Grier Arthur
    Pediatric Surgery International, 2018, 34 : 71 - 74
  • [27] Hidden morbidity of ethanol lock therapy
    Meckmongkol, Teerin T.
    Costanzo, Caitlyn
    Ciullo, Sean
    Prasad, Rajeev
    Arthur, L. Grier
    PEDIATRIC SURGERY INTERNATIONAL, 2018, 34 (01) : 71 - 74
  • [28] Daptomycin Antibiotic Lock Therapy in a Rat Model of Staphylococcal Central Venous Catheter Biofilm Infections
    Van Praagh, Andrew D. G.
    Li, Tongchuan
    Zhang, Shuxin
    Arya, Anu
    Chen, Liping
    Zhang, Xi-Xian
    Bertolami, Shellie
    Mortin, Lawrence I.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2011, 55 (09) : 4081 - 4089
  • [29] Taurolidine Lock Is Superior to Heparin Lock in the Prevention of Catheter Related Bloodstream Infections and Occlusions
    Olthof, Evelyn D.
    Versleijen, Michelle W.
    Huisman-de Waal, Getty
    Feuth, Ton
    Kievit, Wietske
    Wanten, Geert J. A.
    PLOS ONE, 2014, 9 (11):
  • [30] Optimization of Voriconazole Therapy for the Treatment of Invasive Fungal Infections in Adults
    Mangal, Naveen
    Hamadeh, Issam S.
    Arwood, Meghan J.
    Cavallari, Larisa H.
    Samant, Tanay S.
    Klinker, Kenneth P.
    Bulitta, Jurgen
    Schmidt, Stephan
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2018, 104 (05) : 957 - 965